Clinical outcomes research is a core activity of the CIBMTR. Investigators are invited to propose studies that utilize the CIBMTR’s large Research Database. These studies culminate in publications in peer-reviewed journals and move the field of hematopoietic cell transplantation (HCT) and cellular therapy toward improved outcomes and higher quality of life. Since its inception in 1972, CIBMTR data and statistical support have resulted in more than 1,500 publications addressing HCT and other cellular therapy. 

The Clinical Outcomes Research Program includes retrospective studies under the Working Committee or Corporate Program structure. Working Committee studies are guided by Chairs who are experts in the relevant field and by Scientific Directors who are experienced transplant physicians with MS degrees in biostatistics or related fields. MS-level biostatisticians coordinate Working Committee activities and participate in individual studies, and Statistical Directors provide oversight. Investigators from around the world are currently participating in more than 170 CIBMTR studies. 

Learn more about: 

• How to get involved in a Working Committee 
  
• How to propose a study
• The study development and management process
• Planned, in-progress, and recently published studies